National Research (NASDAQ:NRC) Reaches New 52-Week Low at $29.58

National Research Co. (NASDAQ:NRC)’s share price hit a new 52-week low on Thursday . The stock traded as low as $29.58 and last traded at $29.58, with a volume of 837 shares traded. The stock had previously closed at $29.76.

Analyst Ratings Changes

Separately, TheStreet downgraded shares of National Research from a “b-” rating to a “c+” rating in a report on Thursday, January 11th.

National Research Trading Down 0.7 %

The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.60. The stock’s 50 day moving average price is $37.13 and its 200-day moving average price is $39.20. The stock has a market capitalization of $704.53 million, a P/E ratio of 23.81 and a beta of 0.45.

National Research (NASDAQ:NRC) last posted its earnings results on Tuesday, February 13th. The company reported $0.36 EPS for the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%. The company had revenue of $38.00 million during the quarter.

National Research Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Friday, March 29th were issued a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.62%. National Research’s dividend payout ratio is currently 38.40%.

Institutional Trading of National Research

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NRC. iA Global Asset Management Inc. acquired a new stake in shares of National Research in the third quarter valued at about $11,124,000. Comerica Bank acquired a new stake in shares of National Research in the third quarter valued at about $6,939,000. Norden Group LLC acquired a new stake in shares of National Research in the first quarter valued at about $5,170,000. PineStone Asset Management Inc. grew its position in shares of National Research by 128.9% in the fourth quarter. PineStone Asset Management Inc. now owns 153,100 shares of the company’s stock valued at $6,057,000 after purchasing an additional 86,202 shares during the period. Finally, Conestoga Capital Advisors LLC lifted its stake in shares of National Research by 6.0% in the third quarter. Conestoga Capital Advisors LLC now owns 773,215 shares of the company’s stock worth $34,308,000 after buying an additional 43,475 shares in the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.